Biochemical and molecular study on serum miRNA-16a and miRNA- 451 as neonatal sepsis biomarkers
Open Access
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 25, 100915
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Circulating MicroRNAs as Biomarkers for SepsisInternational Journal of Molecular Sciences, 2016
- miRNAs: A New Method for Erythroid Differentiation of Hematopoietic Stem Cells Without the Presence of Growth FactorsApplied Biochemistry and Biotechnology, 2013
- The Potential Role of miR-451 in Cancer Diagnosis, Prognosis, and TherapyMolecular Cancer Therapeutics, 2013
- Serum MicroRNA Signatures Identified by Solexa Sequencing Predict Sepsis Patients’ Mortality: A Prospective Observational StudyPLOS ONE, 2012
- Evidence for serum miR-15a and miR-16 levels as biomarkers that distinguish sepsis from systemic inflammatory response syndrome in human subjectsClinical Chemistry and Laboratory Medicine (CCLM), 2012
- Neonatal sepsis: Role of a battery of immunohematological tests in early diagnosisInternational Journal of Applied & Basic Medical Research, 2012
- New Approaches to Preventing, Diagnosing, and Treating Neonatal SepsisPLOS Medicine, 2010
- Burden of Neonatal Infections in Developing CountriesThe Pediatric Infectious Disease Journal, 2009
- Clustering and conservation patterns of human microRNAsNucleic Acids Research, 2005
- Molecular Epidemiology of Systemic Infection Caused byEnterobacter cloacaein a High-Risk Neonatal Intensive Care UnitInfection Control & Hospital Epidemiology, 2003